Patents by Inventor Jan Lindy Soerensen

Jan Lindy Soerensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of acylating a peptide or protein
    Patent number: 8791236
    Abstract: A method for selectively acylating an amino group in a peptide or protein which has two or more reactive nucleophilic functional groups is described.
    Type: Grant
    Filed: January 28, 2014
    Date of Patent: July 29, 2014
    Assignee: Novo Nordisk A/S
    Inventors: Caspar Christensen, Rune Severinsen, Anders Klarskov Petersen, Steffen Kidal, Claus U. Jessen, Peter Madsen, Henrik Valore, Tina Moeller Tagmose, Jan Lindy Soerensen
  • Method of Acylating a Peptide or Protein
    Publication number: 20140142280
    Abstract: A method for selectively acylating an amino group in a peptide or protein which has two or more reactive nucleophilic functional groups is described.
    Type: Application
    Filed: January 28, 2014
    Publication date: May 22, 2014
    Applicant: Novo Nordisk A/S
    Inventors: Caspar Christensen, Rune Severinsen, Anders Klarskov Petersen, Steffen Kidal, Claus U. Jessen, Peter Madsen, Henrik Valore, Tina Moeller Tagmose, Jan Lindy Soerensen
  • Method of acylating a peptide or protein
    Patent number: 8637647
    Abstract: A method has for selectively acylating an amino group in a peptide or protein which has two or more reactive nucleophilic functional groups is described.
    Type: Grant
    Filed: September 11, 2009
    Date of Patent: January 28, 2014
    Assignee: Novo Nordisk A/S
    Inventors: Caspar Christensen, Rune Severinsen, Anders Klarskov Petersen, Steffen Kidal, Claus U. Jessen, Peter Madsen, Henrik Valore, Tina Møller Tagmose, Jan Lindy Sørensen
  • Method of Acylating a Peptide or Protein
    Publication number: 20110213131
    Abstract: A method has for selectively acylating an amino group in a peptide or protein which has two or more reactive nucleophilic functional groups is described.
    Type: Application
    Filed: September 11, 2009
    Publication date: September 1, 2011
    Applicant: Novo Nordisk A/S
    Inventors: Caspar Christensen, Rune Severinsen, Anders Klarskov Petersen, Steffen Kidal, Claus U. Jessen, Peter Madsen, Henrik Valore, Tina Møller Tagmose, Jan Lindy Sørensen
  • Substituted piperazines and diazepanes
    Patent number: 7208497
    Abstract: A novel class of substituted piperazines and diazepanes, pharmaceutical compositions comprising them and use thereof in the treatment of diseases and disorders related to the histamine H3 receptor. More particularly, the compounds are useful for the treatment of diseases and disorders in which an interaction with the histamine H3 receptor is beneficial.
    Type: Grant
    Filed: June 27, 2002
    Date of Patent: April 24, 2007
    Assignee: Novo Nordisk A/S
    Inventors: Florencio Zaragoza Dorwald, Knud Erik Andersen, Jan Lindy Sørensen